This week, reports appeared that former US President Donald Trump, the Trump Organization of which he is the principal owner, and other people connected to the Trump Organization are the subjects of a special grand jury investigation going on in New York City. As the Washington Post reported,
Manhattan’s district attorney has convened the grand jury that is
expected to decide whether to indict former president Donald Trump,
other executives at his company or the business itself, should
prosecutors present the panel with criminal charges, according to two
people familiar with the development.
Furthermore,
The move indicates that District Attorney Cyrus R. Vance Jr.’s
investigation of the former president and his business has reached an
advanced stage after more than two years. It suggests, too, that Vance
thinks he has found evidence of a crime — if not by Trump, by someone
potentially close to him or by his company.
Vance’s
investigation is expansive, according to people familiar with the probe
and public disclosures made during related litigation. His
investigators are scrutinizing Trump’s business practices before he was
president, including whether the value of specific properties in the
Trump Organization’s real estate portfolio were manipulated in a way
that defrauded banks and insurance companies, and if any tax benefits
were obtained illegally through unscrupulous asset valuation.The
district attorney also is examining the compensation provided to top
Trump Organization executives, people familiar with the matter have
said.
To my knowledge, even though the grand jury could return no indictments, such an investigation of a former president and his business is unprecedented in modern times. It suggests the possibility that this particular president was more unethical and corrupt than any other, and that he might turn out to be the only actually criminal president. Thus it suggests that all our concerns about unethical practices, conflicts of interest, and corruption of the Trump administration, and their effects on corruption in other sectors, particularly health care, were not unfounded.
Thus, I will take this opportunity to review these concerns.
Background: Health Care Corruption
As we wrote in August, 2017, Transparency International (TI) defines corruption as
Abuse of entrusted power for private gain
In 2006, TI published a report
on health care corruption, which asserted that corruption is widespread
throughout the world, serious, and causes severe harm to patients and
society.
the scale of corruption is vast in both rich and poor countries.
Corruption might mean the difference between life and death for
those in need of urgent care. It is invariably the poor in society who
are affected most by corruption because they often cannot afford bribes
or private health care. But corruption in the richest parts of the world
also has its costs.
has been nearly a taboo topic in the US, anechoic, presumably because its discussion would offend the people it makes rich and powerful. As suggested by the recent Transparency International report on corruption in the pharmaceutical industry,
However, strong control over key processes combined with huge resources
and big profits to be made make the pharmaceutical industry particularly
vulnerable to corruption. Pharmaceutical companies have the
opportunity to use their influence and resources to exploit weak
governance structures and divert policy and institutions away from
public health
objectives and towards their own profit maximising interests.
Presumably the leaders of other kinds of corrupt organizations can do the same.
When health care corruption
is discussed in English speaking developed countries, it is almost
always in terms of a problem that affects some other places, mainly
presumably benighted less developed
countries. At best, the corruption in developed countries that gets
discussed is at low levels.
In the US, frequent examples are the “pill mills” and various cheating
of
government and private insurance programs by practitioners and
patients. Lately these have gotten even more attention as they are
decried as a cause of the narcotics (opioids) crisis (e.g., look here). In contrast, the US government has been less inclined to address the
activities of the leaders of the pharmaceutical companies who have
pushed legal narcotics (e.g., see this post).
However, Health Care Renewal has stressed “grand corruption,” or the
corruption of health care leaders. We have noted the continuing impunity of top health care corporate managers. Health care corporations have allegedly used kickbacks and fraud to enhance their revenue, but at best such corporations have been able to make legal settlements
that result in fines that small relative to their multi-billion
revenues without admitting guilt. Almost never are top corporate
managers subject to any negative consequences.
We have been posting about this for years at Health Care Renewal, while seeing little progress on this issue.
Health Care Corruption in the Context of a Corrupt Government
Instead, things from 2017 – 2021 only seemed to be getting worse, given the increasing evidence that
the Trump administration was corrupt at the highest levels. In January,
2018, we first raised the question about how health care corruption could be pursued under a corrupt regime. We noted sources that
summarized Trump’s. the Trump family’s, and the Trump administration’s
corruption.. These included a website, entitled “Tracking Trump’s Conflicts of Interest” published by the Sunlight Foundation, and two articles published in the Washington Monthly in January, 2018. “Commander-in-Thief,” categorized Mr Trump’s conflicted and corrupt behavior. A Year in Trump Corruption,” was a catalog of the most salient cases in these categories in 2017.
In July, 2018, we addressed the Trump regime’s corruption again By then, more summaries of Trump et al corruption had appeared. In April, 2018, New York Magazine published “501 Days in Swampland,” a time-line of starting just after the 2016 presidential election. In June, 2018, ProPublica reviewed
questionable spending amounting to $16.1 million since the beginning of
Trump’s candidacy for president at Trump properties by the US
government, and by Trump’s campaign, and by state and local governments. Meanwhile, Public Citizen released a report on money spent at Trump’s hospitality properties.
In October, 2018, we summarized the content of the voluminous Tracking Corruption and Conflicts of Interest in the Trump Administration summary appearing in the Global Anti-Corruption Blog. The blog organized corrupt activities within the Trump administration into the following categories:
1. U.S. Government Payments to the Trump Organization
2. Use of the Power of the Presidency to Promote Trump Brands
3. U.S. Government Regulatory and Policy Decisions that Benefit Business Interests of the Trump Family and Senior Advisors
4. Private and Foreign Interests Seeking to Influence the Trump Administration Through Dealings with Trump Businesses
Not only was the report voluminous, the October, 2018, version of the report
requiring 26 pages to print, it suggested that many examples of
corruption by Trump et al were not one-offs, but were long-term
activities. For example, every time President Trump travels to on of
the properties he owns through the Trump Organization, for example, has
Mar-a-Lago resort in Florida, the US government is obligated to pay
Trump himself through that organization for various expenses, e.g., the
Secret Service renting golf carts at Mar-a-Lago. Each time that happens
it seems to violate the “domestic emolument clause” of the US
Constitution, which prohibits state or US government payments to a
President for anything other than his salary. Also, foreign governments
and corporations seeking to promote specific government policies in
their self-interest, similarly seeking favorable regulations, or other
seeking to influence government actions in their favor are making
periodic payments to the Trump Organization, such as buying
accommodations or paying for events at Trump properties. When foreign
governments do so, that appears to violate the “foreign emoluments
clause” of the US Constitution, which prohibits payments by a foreign
government to the US President.
Further reports on Trump and associates’ conflicts of interest and corruption appeared through 2019, as further documented in this post.
Discussion
We noted in our last summary post on conflicts of interest and corruption in the Trump administration that the topics of corruption, health care corruption, and the likely corruption of the Trump administration remained largely anechoic.
Despite the extensive and ever-increasing list of apparently corrupt
acts by the Trump and cronies, grand corruption at the top of US
government, with its potential to corrupt not just health care, but the
entire country and society, still seems like a taboo topic. The US news
media continues to tip-toe around the topic of corruption, in health
care, of top health care leaders, and in government, including the top
of the US executive branch. As long as such discussion seems taboo, how
can we ever address, much less reduce the scourge of corruption? The
first step against health care
corruption is to be able to say or write the words, health care
corruption.
Once Trump left office, there has not been much more discussion. There have been brief reports in the media that many investigations of Trump and cronies are ongoing. For example, an article in the
Washington Post in March 2021 noted “the [NY] state attorney general has subpoenaed his lawyers, his bankers, his chief financial officer — even one of his sons…. Former president Donald Trump is also facing criminal investigations in Georgia and the District of Columbia related to his efforts to overturn the 2020 election.” Also, “In Washington, D.C. Attorney General Karl A. Racine (D) has also opened a criminal investigation into Trump’s actions on Jan. 6” and “the Justice Department, in the meantime, is conducting a broad investigation of the Jan. 6 Capitol attack.” Yet, as we documented here, prior to becoming president, Trump and his associates enjoyed practical impunity, escaping convictions and penalties multiple times. There is no certainty he will not maintain his impunity in the future.
Trump is no longer president, but he enjoys continuing support from many in his party, and has suggested he might run again. How will we ever make a meaningful dent in health care corruption if we cannot end the impunity of our top political leadership?
